Comparative effects of angiotensin II receptor blockade (candesartan) with angiotensin-converting enzyme inhibitor (quinapril) in rats with dilated cardiomyopathy

Journal of Cardiovascular Pharmacology

Volumn 41, Issue SUPPL. 1, 2003, Pages

  Watanabe, Kenichi ^a   Juan, Wen ^a   Narasimman, Gurusamy ^a   Ma, Meilei ^a   Inoue, Mikio ^a   Saito, Yuki ^a   Wahed, Mir I I ^a   Nakazawa, Mikio ^b   Hasegawa, Go ^c   Naito, Makoto ^c   Tachikawa, Hitoshi ^c   Tanabe, Naohito ^c   Kodama, Makoto ^c   Aizawa, Yoshifusa ^c   Yamamoto, Tadashi ^c   Yamaguchi, Kenichi ^c   Takahashi, Toshihiro ^c  

^a NIIGATA UNIVERSITY OF PHARMACY AND APPLIED LIFE SCIENCES   (Japan)

^b NIIGATA UNIVERSITY   (Japan)

^c NIIGATA UNIVERSITY GRADUATE SCHOOL OF MEDICAL AND DENTAL SCIENCES   (Japan)

Author keywords

Angiotensin receptor blockade; Angiotensin converting enzyme inhibitor; Candesartan; Heart failure; Quinapril; Transforming growth factor

Indexed keywords

ANGIOTENSIN; ANGIOTENSIN RECEPTOR ANTAGONIST; CANDESARTAN; COLLAGEN TYPE 3; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; MESSENGER RNA; METHYLCELLULOSE; QUINAPRIL; TRANSFORMING GROWTH FACTOR BETA1;

ANIMAL MODEL; CARDIOMYOPATHY; CARDIOVASCULAR DISEASE; CONFERENCE PAPER; CONTROLLED STUDY; DISEASE COURSE; DRUG EFFECT; HEART DILATATION; HEMODYNAMIC PARAMETERS; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM;

ANGIOTENSIN I; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; ANIMALS; BENZIMIDAZOLES; CARDIOMYOPATHY, DILATED; ISOQUINOLINES; MALE; RATS; RATS, INBRED LEW; RECEPTORS, ANGIOTENSIN; TETRAHYDROISOQUINOLINES; TETRAZOLES;

EID: 12244249865     PISSN: 01602446     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (22)

1. CONSENSUS trial study group. Effects of enalapril on mortality in severe congestive heart failure: Results of the Cooperative North Scandinavian Enalapril Survival Study (CONSENSUS). N Engl J Med 1987;316:1429-35.
2. Cohn JN, Johnson G, Ziesche S, et al. A comparison of enarapril with hydralazine-isosorbide dinitrate in the treatment of congestive heart failure. N Engl J Med 1991;324:303-10.
3. SOLVD investigators. Effects of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure. N Engl J Med 1991;325:293-302.
4. Weinberg EO, Schoen FJ, George D, et al. Angiotensin-converting enzyme inhibition prolongs survival and modifies the transition to heart failure in rats with pressure overload hypertrophy due to ascending aortic stenosis. Circulation 1994;90:1410-22.
5. Litwin SE, Kats SE, Weinberg EO, et al. Serial echocardiographic-Doppler assessment of left ventricular geometry and function in rats with pressure-overload hypertrophy. Chronic angiotensin-converting enzyme inhibition attenuates the transition to heart failure. Circulation 1995;91:2642-54.
6. Lonn EM, Yusuf S, Jha P, et al. Emerging role of angiotensin-converting enzyme inhibitors in cardiac and vascular protection. Circulation 1994;90:2056-69.
7. Linz W, Wiemer G, Gohlke P, et al. Contributions of kinins to the cardiovascular actions of angiotensin-converting enzyme inhibitors. Pharmacol Rev 1995;47:25-49.
8. Weber KT, Brilla CG. Pathological hypertrophy and cardiac interstitium. Fibrosis and renin-angiotensin-aldosterone system. Circulation 1991;83:1849-65.
9. Swynghedauw B. Molecular mechanisms of myocardial remodeling. Physiol Rev 1999;79:215-62.
10. Powell J, Clozel J, Muller R, et al. Inhibitors of angiotensin-converting enzyme prevent myointimal proliferation after vascular injury. Science 1989;245:186-8.
11. Schelling P, Fisher PH, Ganten D. Angiotensin and cell growth: A link to cardiovascular hypertrophy. J Hypertens 1991;9:3-15.
12. Ma M, Watanabe K, Wahed IIM, et al. Inhibition of progression of heart failure and expression of TGF-β1 mRNA in rats with heart failure by the ACE inhibitor quinapril. J Cardiovasc Pharmacol 2001;38:S51-4.
13. Kodama M, Hanawa H, Saeki M, et al. Rat dilated cardiomyopathy after autoimmune giant cell myocarditis. Circ Res 1994;75:278-84.
14. Watanabe K, Ohta Y, Nakazawa M, et al. Low dose carvedilol inhibits progression of heart failure in rats with dilated cardiomyopathy. Br J Pharmacol 2000; 130:1489-95.
15. Ruzicka M, Skarda V, Leenen HHF, et al. Effects of ACE inhibitors on circulating versus cardiac angiotensin II in volume overload-induced cardiac hypertrophy in rats. Circulation 1995;92:3568-73.
16. Ohta Y, Watanabe K, Nakazawa M, et al. Carvedilol enhances atrial and brain natriuretic peptide mRNA expression and release in rat heart. J Cardiovasc Pharmacol 2000;36(suppl 2):S 19-23.
17. Chomczynski P, Sacchi N. Single-step method of mRNA by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem 1987;162:156-9.
18. Fujinaka H, Yamamolto T, Feng L, et al. Crucial role of CD8-positive lymphocytes in glomerular expression of ICAM-1 and cytokines in crescentic glomerulonephritis of WKY rats. J Immunol 1997;158:4978-83.
19. Juan W, Nakazawa M, Watanabe K, et al. Quinapril inhibits progression of heart failure and fibrosis in rats with dilated cardiomyopathy after myocarditis. Mol Cell Biochem 2002 (in press).
20. Inada Y, Wada T, Shibouta Y, et al. Antihypertensive effects of a highly potent and long-acting angiotensin II subtype-1 receptor antagonist, ±-1-cyclohexycarbonyloxy ethyl 2-ethoxy-1-2-1H-tetrazol-5-yl biphenyl-4-yl methyl-1H-benzimidazole-7-carboxylate (TCV-116), in various hypertensive rats. J Pharm Exp Ther 1994;268:1540-7.
21. Matsubara H. Pathophysiological fore of angiotensin II type 2 receptor in cardiovascular and renal diseases. Circ Res 1998;83:1182-91.
22. Kim S, Yoshiyama M, Izumi Y, et al. Effects of combination of ACE inhibitor and angiotensin receptor blocker on cardiac remodeling, cardiac function, and survival in rat heart failure. Circulation 2001; 103:148-54.